Entecavir IP 0.5 mg .. ..

ENTACOVER 0.5
Entecavir IP (0.5mg)
Entecavir is an antiviral medication used to treat chronic hepatitis B infection. It is available in various formulations and strengths, including tablets and solutions. The notation "Entecavir IP (0.5mg)" indicates that it contains 0.5 milligrams of the active ingredient entecavir.

Here are some key points about ENTACOVER 0.5 :

Purpose: ENTACOVER 0.5 is prescribed for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients (aged 2 years and older) with evidence of active viral replication and liver inflammation.

Mechanism of Action: ENTACOVER 0.5 works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of hepatitis B virus. By doing so, it reduces the viral load in the body and can slow down the progression of liver disease associated with chronic HBV infection.

Dosage: The dosage of ENTACOVER 0.5 can vary depending on factors like the patient's age, weight, and the severity of their hepatitis B infection. A healthcare provider will determine the appropriate dosage and treatment duration based on individual factors.

Duration of Treatment: The treatment duration with Entecavir can be long-term, often lasting for several years. It is essential to follow your healthcare provider's instructions and continue treatment as prescribed to effectively manage hepatitis B.

Monitoring: During Entecavir treatment, regular monitoring of liver function and HBV viral load is typically performed to assess the response to therapy and adjust treatment if necessary.

Safety and Side Effects: Entecavir is generally well-tolerated, but it can cause side effects, including headache, dizziness, fatigue, and nausea. More serious side effects are rare but can include lactic acidosis and severe liver problems. Patients should report any unusual or severe symptoms to their healthcare provider promptly.

Precautions: Entecavir is not a cure for hepatitis B, and discontinuing the medication can lead to a recurrence of the infection. It's essential to use it as directed by a healthcare provider and to avoid missing doses. Individuals with kidney problems may require dose adjustments.

Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, it's important to discuss the potential risks and benefits of Entecavir with your healthcare provider, as the safety of this medication during pregnancy and breastfeeding is not well established.

It's crucial to consult with a healthcare provider for a thorough evaluation and diagnosis if you suspect you have chronic hepatitis B. Treatment with Entecavir, or any other antiviral medication, should be initiated and managed under the supervision of a qualified healthcare professional.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com